A Study to Assess How Well the Study Medicine IPN60340 Works in Combination With Azacitidine and Venetoclax, Compared to Placebo in Combination With Azacitidine and Venetoclax, in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Cannot Receive Intensive Chemotherapy

Clinical trial NCT07623187 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07623187
Sponsor: Ipsen
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukaemia (AML)Acute Myeloid Leukaemia

Start date: 2026-11-01
Primary completion: 2031-05-31
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.